524 results on '"Klein, Helmut U."'
Search Results
2. Die Geschichte des implantierbaren Kardioverter-Defibrillators in Deutschland
3. Geschichte der chirurgischen Behandlung von Herzrhythmusstörungen in Deutschland: Chirurgische Therapie ventrikulärer Tachykardien sowie supraventrikulärer Tachykardien, insbesondere Präexzitationssyndromen (WPW)
4. Comparison of symptomatic and functional responses to vagus nerve stimulation in ANTHEM‐HF, INOVATE‐HF, and NECTAR‐HF
5. History of the implantable cardioverter–defibrillator in Germany
6. Protected risk stratification with the wearable cardioverter-defibrillator: results from the WEARIT-II-EUROPE registry
7. Left Ventricular Lead Location and Long-Term Outcomes in Cardiac Resynchronization Therapy Patients
8. Abstract 16194: Prior Atrial Fibrillation and WCD-detected Arrhythmic Outcomes - Data From the WEARIT-II Prospective Registry
9. Impact of Autonomic Regulation Therapy in Patients with Heart Failure: ANTHEM-HFrEF Pivotal Study Design
10. Right ventricular lead location, right-left ventricular lead interaction, and long-term outcomes in cardiac resynchronization therapy patients
11. Correction to: Protected risk stratification with the wearable cardioverter-defibrillator: results from the WEARIT-II-EUROPE registry
12. „Mismanagement“ oder „misunderstanding“?
13. Sustained clinical benefit of cardiac resynchronization therapy in non-LBBB patients with prolonged PR-interval: MADIT-CRT long-term follow-up
14. Do we need sex-specific guidelines?
15. Impact of atrial fibrillation on early complications and one year-survival after cardioverter defibrillator implantation: Results from the German DEVICE registry
16. A Hero behind the curtain in memoriam of Dr. Morton M. Mower
17. Advances in Our Clinical Understanding of Autonomic Regulation Therapy Using Vagal Nerve Stimulation in Patients Living With Heart Failure
18. Effect on Cardiac Function of Cardiac Resynchronization Therapy in Patients With Right Bundle Branch Block (from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy [MADIT-CRT] Trial)
19. PO-06-067 ARRHYTHMIC OUTCOMES ASSOCIATED WITH HISTORY OF NON-SUSTAINED VENTRICULAR TACHYCARDIA IN PRIMARY PREVENTION ICD RECIPIENTS
20. PO-06-039 MULTICENTER AUTOMATIC DEFIBRILLATOR IMPLANTATION TRIAL – SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR: MADIT S-ICD
21. Safety of the Wearable Cardioverter Defibrillator (WCD) in Patients with Implanted Pacemakers
22. The wearable cardioverter-defibrillator: current technology and evolving indications
23. Long-term outcome with cardiac resynchronization therapy in mild heart failure patients with left bundle branch block from US and Europe MADIT-CRT
24. Reverse Remodeling and the Risk of Ventricular Tachyarrhythmias in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy)
25. Apical vs. non-apical right ventricular pacing in cardiac resynchronization therapy: a meta-analysis
26. The Wearable Cardioverter Defibrillator—Bridge to the Implantable Defibrillator
27. Cardiac resynchronization therapy with- or without defibrillator. Estimating the risk of arrhythmic death or assessing the likelihood of non-arrhythmic mortality?
28. Cardiac Resynchronization Therapy in Asymptomatic or Mildly Symptomatic Heart Failure Patients
29. Survival with Cardiac-Resynchronization Therapy in Mild Heart Failure
30. Angiotensin II Antagonist in Paroxysmal Atrial Fibrillation (ANTIPAF) Trial: Rationale and Study Design
31. Electroatriography – Time-frequency analysis of atrial fibrillation from modified 12-lead ECG configurations for improved diagnosis and therapy
32. Quality of anticoagulation with unfractionated heparin plus phenprocoumon for the prevention of thromboembolic complications in cardioversion for non-valvular atrial fibrillation. Sub-analysis from the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial
33. Erratum to: “Mismanagement” oder “misunderstanding”?
34. Effect of Physical Exercise on Platelet Activity and the von-Willebrand-Factor in Patients with Persistent Lone Atrial Fibrillation
35. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator
36. Erste Erfahrungen mit einem tragbaren automatischen Defibrillator (WCD®) zur Prävention des plötzlichen Herztodes
37. Case Report: Severe Skin Burn at the Site of the Indifferent Electrode After Radiofrequency Catheter Ablation of Typical Atrial Flutter
38. Frequent Implantable Cardioverter-Defibrillator Discharges—What Have We Learned?
39. Expansion of ICD Indications: Resynchronization Therapy and the ICD
40. Time Dependence of Defibrillator Benefit After Coronary Revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II
41. Evaluation of noncardiac chest pain: diagnostic approach, coping strategies and quality of life
42. Perspectives: Does Amiodarone Increase Non-sudden Deaths? If so, Why?
43. The MUSTT Study: Evaluating Testing and Treatment
44. Calpains and cytokines in fibrillating human atria
45. Preventive cardiac resynchronisation therapy
46. Successful use of a wearable cardioverter-defibrillator in myocarditis with normal ejection fraction
47. Effect of Elapsed Time From Coronary Revascularization to Implantation of a Cardioverter Defibrillator on Long-Term Survival in the MADIT-II Trial
48. Asymmetric dimethylarginine predicts appropriate implantable cardioverter–defibrillator intervention in patients with left ventricular dysfunction
49. Improved Outcome with Preventive Cardiac Resynchronization Therapy in the Elderly: A MADIT-CRT Substudy
50. Response to preventive cardiac resynchronization therapy in patients with ischaemic and nonischaemic cardiomyopathy in MADIT-CRT
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.